Accessibility Menu
 
Penumbra logo

Penumbra

(NYSE) PEN

Current Price$329.09
Market Cap$12.89B
Since IPO (2015)+695%
5 Year+20%
1 Year+21%
1 Month-4%

Penumbra Financials at a Glance

Market Cap

$12.89B

Revenue (TTM)

$1.40B

Net Income (TTM)

$177.69M

EPS (TTM)

$4.52

P/E Ratio

72.59

Dividend

$0.00

Beta (Volatility)

1.03 (Average)

Price

$329.09

Volume

35,235

Open

$329.81

Previous Close

$329.09

Daily Range

$328.11 - $330.45

52-Week Range

$221.26 - $362.41

PEN: Motley Fool Moneyball Superscore

76

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Penumbra

Industry

Healthcare Equipment and Supplies

Employees

4,700

CEO

Adam Elsesser

Headquarters

Alameda, CA 94502, US

PEN Financials

Key Financial Metrics (TTM)

Gross Margin

67%

Operating Margin

13%

Net Income Margin

13%

Return on Equity

14%

Return on Capital

12%

Return on Assets

10%

Earnings Yield

1.38%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.89B

Shares Outstanding

39.24M

Volume

35.23K

Short Interest

0.00%

Avg. Volume

1.04M

Financials (TTM)

Gross Profit

$942.44M

Operating Income

$189.25M

EBITDA

$222.60M

Operating Cash Flow

$238.66M

Capital Expenditure

$63.73M

Free Cash Flow

$174.93M

Cash & ST Invst.

$186.90M

Total Debt

$219.70M

Penumbra Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$385.38M

+22.1%

Gross Profit

$262.13M

+24.4%

Gross Margin

68.02%

N/A

Market Cap

$12.89B

N/A

Market Cap/Employee

$2.86M

N/A

Employees

4,500

N/A

Net Income

$47.34M

+40.6%

EBITDA

$68.09M

+38.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$32.80M

-128.1%

Accounts Receivable

$190.02M

+13.3%

Inventory

$431.55M

+6.1%

Long Term Debt

$203.47M

-2.6%

Short Term Debt

$16.23M

+11.3%

Return on Assets

9.73%

N/A

Return on Invested Capital

11.52%

N/A

Free Cash Flow

$68.05M

+48.8%

Operating Cash Flow

$86.48M

+69.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALGNAlign Technology, Inc.
$172.73+0.76%
GMEDGlobus Medical, Inc.
$87.74+1.83%
DVADaVita Inc.
$150.34-2.18%
BAXBaxter International Inc.
$16.78-0.12%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%

Questions About PEN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.